glycan target specialist

Tacalyx Raises €14m to Develop Cancer Therapies

1. 🌱 Tacalyx raises €14m in seed financing to develop anti-TACA cancer therapies. Exciting advancements in cancer treatment! 💪🔬🎗️ 2. Tacalyx secures €14m in seed capital financing, led by Thuja Capital. Promising developments in anti-TACA cancer therapies. 🌟💰🔬